Machine Learning: A New Approach to Drug Discovery with Daphne Koller - #332

Today we continue our 2019 NeurIPS coverage joined by Daphne Koller, co-Founder and former co-CEO of Coursera and Founder and CEO of Insitro. We caught up with Daphne to discuss: Her background in machine learning, beginning in ‘93, and her work with the Stanford online machine learning courses, and eventually her work at Coursera. The current landscape of pharmaceutical drug discovery, including the current pricing of drugs and misnomers with why drugs are so expensive, Her work at Insitro, a compan
Back to Top